Outcome of multidisciplinary treatment of peripheral primitive neuroectodermal tumor

[1]  P. Sarkar,et al.  Current Status and Outlook for Future , 2022, Understanding Properties of Atoms, Molecules and Materials.

[2]  Jieyu Chen,et al.  Comparison of clinical features and outcomes in patients with extraskeletal vs skeletal Ewing sarcoma: an SEER database analysis of 3,178 cases , 2018, Cancer management and research.

[3]  J. Blay,et al.  High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  E. van Limbergen,et al.  Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma , 2017, Sarcoma.

[5]  J. Blay,et al.  A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome , 2017, Scientific Reports.

[6]  S. Ince,et al.  Late onset of primary pulmonary primitive neuroectodermal tumor: a case report , 2017, Clujul medical.

[7]  V. Gopalakrishnan,et al.  Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. , 2017, The oncologist.

[8]  C. Raut,et al.  Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy. , 2017, The oncologist.

[9]  J. Mora,et al.  GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS) , 2017, British Journal of Cancer.

[10]  C. R. Galia,et al.  What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group – EWING1 , 2017, BMC Cancer.

[11]  C. R. Galia,et al.  What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group – EWING1 , 2017, BMC Cancer.

[12]  N. Toumi,et al.  A Review of Ewing Sarcoma Treatment: Is it Still a Subject of Debate? , 2017, Reviews on recent clinical trials.

[13]  Satyashiva Munjal,et al.  Primary dorsal spine primitive neuroectodermal tumor in an adult patient: Case report and literature review , 2017, Journal of craniovertebral junction & spine.

[14]  P. Tamboli,et al.  Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases , 2017, Pathology & Oncology Research.

[15]  S. Lessnick,et al.  Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group , 2015, Pediatric blood & cancer.

[16]  B. Knebelmann,et al.  Case report and literature review , 2016, Medicine.

[17]  S. Viswanath,et al.  Primitive neuroectodermal tumor of lungs in adults: a rare series of three cases treated with upfront chemo-radiation. , 2016, Translational lung cancer research.

[18]  Jun Yang,et al.  Comparison of Primary Spinal Central and Peripheral Primitive Neuroectodermal Tumors in Clinical and Imaging Characteristics and Long-Term Outcome. , 2016, World neurosurgery.

[19]  S. Lessnick,et al.  Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting , 2016, Oncotarget.

[20]  C. Rodríguez-Galindo,et al.  Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian Collaborative Study Group for Ewing Sarcoma Family Tumors—EWING1 , 2015, Pediatric blood & cancer.

[21]  U. Dirksen,et al.  Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Kumar,et al.  Histological diversity and clinical characteristics of Ewing sarcoma family of tumors in children: A series from a tertiary care center in South India. , 2015, Indian journal of cancer.

[23]  U. Dirksen,et al.  Local Control in Ewing Sarcoma of the Chest Wall: Results of the EURO-EWING 99 Trial , 2015, Annals of Surgical Oncology.

[24]  S. Donaldson,et al.  Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group , 2015, Cancer.

[25]  U. Dirksen,et al.  Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  P. Rose,et al.  Adult Ewing Sarcoma: Survival and Local Control Outcomes in 102 Patients with Localized Disease , 2013, Sarcoma.

[27]  Their Families,et al.  LONG-TERM OUTCOMES , 2013 .

[28]  J. Neuhaus,et al.  Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis. , 2013, Cancer epidemiology.

[29]  Daniele Marchioni,et al.  A Single-Institution Experience , 2013 .

[30]  J. Healey,et al.  Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  A. Amirjamshidi,et al.  Primary spinal extradural Ewing's sarcoma (primitive neuroectodermal tumor): Report of a case and meta-analysis of the reported cases in the literature , 2012, Surgical neurology international.

[32]  D. Hawkins,et al.  Ewing sarcoma/primitive neuroectodermal tumor arising from the adrenal gland in an adolescent , 2011, Pediatric blood & cancer.

[33]  D. Indelicato,et al.  Chest wall Ewing sarcoma family of tumors: long-term outcomes. , 2011, International Journal of Radiation Oncology, Biology, Physics.

[34]  S. Ferrari,et al.  Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  N. A. Kumarasamy,et al.  Retroperitoneal sarcomas. , 2011, Seminars in ultrasound, CT, and MR.

[36]  U. Dirksen,et al.  Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  L. Marinova.  Retroperitoneal primitive neuroectodermal tumour (PNET). A case report and review of the literature , 2009 .

[38]  P. Leavey,et al.  Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  A. Demir,et al.  Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the Thorax , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[40]  J. Hinojosa,et al.  Purely intramedullary spinal cord primitive neuroectodermal tumor: case report and review of the literature. , 2009, Neurocirugia.

[41]  L. Truong,et al.  Undifferentiated tumor: true identity by immunohistochemistry. , 2009, Archives of pathology & laboratory medicine.

[42]  Wang Jun.  Clinical analysis of 16 patients with peripheral primitive neuroectodermal tumors , 2008 .

[43]  L. Truong,et al.  True Identity by Immunohistochemistry , 2008 .

[44]  I. Judson,et al.  How to treat the Ewing's family of sarcomas in adult patients. , 2006, The oncologist.

[45]  K. Hongo,et al.  A case report and review of the literature , 2006, Journal of Neuro-Oncology.

[46]  F. Tzortzatou-Stathopoulou,et al.  Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: A single institution experience , 2005, Journal of surgical oncology.

[47]  A. Pappo,et al.  Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. , 2003, Medical and pediatric oncology.

[48]  S. Donaldson,et al.  Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. , 2003, The New England journal of medicine.

[49]  W. Winkelmann,et al.  Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. , 2003, International journal of radiation oncology, biology, physics.

[50]  A. Folpe,et al.  Primary Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic and Immunohistochemical Analysis of 11 Cases , 2002, The American journal of surgical pathology.

[51]  M. Ladanyi,et al.  High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  K. Eilber,et al.  Retroperitoneal sarcomas , 2000, Current treatment options in oncology.

[53]  H. Grier.  The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. , 1997, Pediatric clinics of North America.

[54]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[55]  H. Gadner,et al.  Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients , 1988, Cancer.

[56]  M. Hart,et al.  Primitive neuroectodermal tumors of the brain in children , 1973, Cancer.